General Announcement::RIGHTS: OFFER INFORMATION STATEMENT DATED 30 JUNE 2021

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Jun-2021 23:35:03
Status
New
Announcement Sub Title
RIGHTS: OFFER INFORMATION STATEMENT DATED 30 JUNE 2021
Announcement Reference
SG210630OTHRGNDQ
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
The Board of Directors of iX Biopharma Ltd. (the "Company") refers to the announcement dated 30 June 2021 in relation to, amongst others, the lodgement of the offer information statement in connection with the proposed renounceable non-underwritten rights issue of up to 48,814,711 new ordinary shares in the capital of the Company ("Offer Information Statement"). A copy of the Offer Information Statement that was lodged on 30 June 2021 is attached to this announcement.

This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, UOB Kay Hian Private Limited (the "Sponsor") for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr Lance Tan, Senior Vice President at 8 Anthony Road, #01-01, Singapore 229957, telephone (65) 6590 6881.


Attachments

OIS.pdf
Total size =1082K